166 related articles for article (PubMed ID: 10857913)
21. Unsymmetrical oxovanadium complexes derived from salicylaldehyde and phenanthroline: synthesis, DNA interactions, and antitumor activities.
Liao X; Pan W; He R; Guo H; Ying P; Lu J
Chem Biol Drug Des; 2014 Mar; 83(3):367-78. PubMed ID: 24118856
[TBL] [Abstract][Full Text] [Related]
22. Relationship between Antioxidant Activity and Ligand Basicity in the Dipicolinate Series of Oxovanadium(IV) and Dioxovanadium(V) Complexes.
Drzeżdżon J; Pawlak M; Matyka N; Sikorski A; Gawdzik B; Jacewicz D
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576048
[TBL] [Abstract][Full Text] [Related]
23. Model Investigations for Vanadium-Protein Interactions. Synthetic, Structural, and Physical Studies of Vanadium(III) and Oxovanadium(IV/V) Complexes with Amidate Ligands.
Keramidas AD; Papaioannou AB; Vlahos A; Kabanos TA; Bonas G; Makriyannis A; Rapropoulou CP; Terzis A
Inorg Chem; 1996 Jan; 35(2):357-367. PubMed ID: 11666216
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, characterization, and protein tyrosine phosphatases inhibition activities of oxovanadium(IV) complexes with Schiff base and polypyridyl derivatives.
Yuan C; Lu L; Wu Y; Liu Z; Guo M; Xing S; Fu X; Zhu M
J Inorg Biochem; 2010 Sep; 104(9):978-86. PubMed ID: 20542335
[TBL] [Abstract][Full Text] [Related]
25. Synthetic analogs for oxovanadium(IV/V)-glutathione interaction: an NMR, EPR, synthetic and structural study of oxovanadium(IV/V) compounds with sulfhydryl-containing pseudopeptides and dipeptides.
Tasiopoulos AJ; Troganis AN; Deligiannakis Y; Evangelou A; Kabanos TA; Woollins JD; Slawin A
J Inorg Biochem; 2000 Apr; 79(1-4):159-66. PubMed ID: 10830861
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, characterization, and antitumor activity of unusual pseudo five coordinate gold(III) complexes: distinct cytotoxic mechanism or expensive ligand delivery systems?
Olsen PM; Ruiz C; Lussier D; Le BK; Angel N; Smith M; Hwang CB; Khatib R; Jenkins J; Adams K; Getcher J; Tham F; Chen ZG; Wilson EH; Eichler JF
J Inorg Biochem; 2014 Dec; 141():121-131. PubMed ID: 25243390
[TBL] [Abstract][Full Text] [Related]
27. Leishmanicidal activity of polysaccharides and their oxovanadium(IV/V) complexes.
do Amaral AE; Petkowicz CL; Mercê AL; Iacomini M; Martinez GR; Merlin Rocha ME; Cadena SM; Noleto GR
Eur J Med Chem; 2015 Jan; 90():732-41. PubMed ID: 25506811
[TBL] [Abstract][Full Text] [Related]
28. Chemistry and insulin-mimetic properties of bis(acetylacetonate)oxovanadium(IV) and derivatives.
Amin SS; Cryer K; Zhang B; Dutta SK; Eaton SS; Anderson OP; Miller SM; Reul BA; Brichard SM; Crans DC
Inorg Chem; 2000 Feb; 39(3):406-16. PubMed ID: 11229556
[TBL] [Abstract][Full Text] [Related]
29. Ternary oxovanadium(IV) complexes with amino acid-Schiff base and polypyridyl derivatives: synthesis, characterization, and protein tyrosine phosphatase 1B inhibition.
Lu L; Yue J; Yuan C; Zhu M; Han H; Liu Z; Guo M
J Inorg Biochem; 2011 Oct; 105(10):1323-8. PubMed ID: 21864810
[TBL] [Abstract][Full Text] [Related]
30. Copper (II) complexes possessing alkyl-substituted polypyridyl ligands: Structural characterization and in vitro antitumor activity.
Angel NR; Khatib RM; Jenkins J; Smith M; Rubalcava JM; Le BK; Lussier D; Chen ZG; Tham FS; Wilson EH; Eichler JF
J Inorg Biochem; 2017 Jan; 166():12-25. PubMed ID: 27815978
[TBL] [Abstract][Full Text] [Related]
31. Potent dual anti-HIV and spermicidal activities of novel oxovanadium(V) complexes with thiourea non-nucleoside inhibitors of HIV-1 reverse transcriptase.
D'Cruz OJ; Dong Y; Uckun FM
Biochem Biophys Res Commun; 2003 Mar; 302(2):253-64. PubMed ID: 12604339
[TBL] [Abstract][Full Text] [Related]
32. [Anticancer activity of oxovanadium compounds].
Abakumova OIu; Podobed OV; Beliaeva NF; Tochilkin AI
Biomed Khim; 2013; 59(3):305-20. PubMed ID: 23987068
[TBL] [Abstract][Full Text] [Related]
33. In vitro study of the cytotoxicities of two mixed-ligand oxovanadium complexes on human hepatoma cells.
Zhang YL; Wang XS; Fang W; Cai XY; Li HZ; Mao JW; Jin XB; Bai YL; Lu JZ
Pharmazie; 2013 Oct; 68(10):827-34. PubMed ID: 24273888
[TBL] [Abstract][Full Text] [Related]
34. Antioxidant, DNA cleavage, and cellular effects of silibinin and a new oxovanadium(IV)/silibinin complex.
Naso LG; Ferrer EG; Butenko N; Cavaco I; Lezama L; Rojo T; Etcheverry SB; Williams PA
J Biol Inorg Chem; 2011 Apr; 16(4):653-68. PubMed ID: 21399988
[TBL] [Abstract][Full Text] [Related]
35. Ligational behavior of two biologically active N-S donors toward oxovanadium(IV) ion and potentiation of their antibacterial activities by chelation to metal ions. Part III.
Maiti A; Guha AK; Ghosh S
J Inorg Biochem; 1988 May; 33(1):57-65. PubMed ID: 2837531
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, crystal structures, and urease inhibition of an acetohydroxamate-coordinated oxovanadium(V) complex derived from N'-(3-bromo-2-hydroxybenzylidene)-4-methoxybenzohydrazide.
Qu D; Niu F; Zhao X; Yan KX; Ye YT; Wang J; Zhang M; You Z
Bioorg Med Chem; 2015 May; 23(9):1944-9. PubMed ID: 25840795
[TBL] [Abstract][Full Text] [Related]
37. Stepwise Cluster Assembly Using VO(2)(acac) as a Precursor: cis-[VO(OCH(CH(3))(2))(acac)(2)], [V(2)O(2)(&mgr;-OCH(3))(2)(acac)(2)(OCH(3))(2)], [V(3)O(3){&mgr;,&mgr;-(OCH(2))(3)CCH(3)}(2)(acac)(2)(OC(2)H(5))], and [V(4)O(4)(&mgr;-O)(2)(&mgr;-OCH(3))(2)(&mgr;(3)-OCH(3))(2)(acac)(2)(OCH(3))(2)].2CH(3)CN(1).
Jiang F; Anderson OP; Miller SM; Chen J; Mahroof-Tahir M; Crans DC
Inorg Chem; 1998 Oct; 37(21):5439-5451. PubMed ID: 11670686
[TBL] [Abstract][Full Text] [Related]
38. Formations of mixed-valence oxovanadiumV,IV citrates and homocitrate with N-heterocycle chelated ligand.
Chen CY; Zhou ZH; Chen HB; Huang PQ; Tsai KR; Chow YL
Inorg Chem; 2008 Oct; 47(19):8714-20. PubMed ID: 18722422
[TBL] [Abstract][Full Text] [Related]
39. Structure and conformation of bis(acetylacetonato)oxovanadium(IV) and bis(maltolato)oxovanadium(IV) in solution determined by electron nuclear double resonance spectroscopy.
Mustafi D; Makinen MW
Inorg Chem; 2005 Aug; 44(16):5580-90. PubMed ID: 16060607
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and insulinomimetic activities of novel mono- and tetranuclear oxovanadium(IV) complexes with 3-hydroxypyridine-2-carboxylic acid.
Nakai M; Obata M; Sekiguchi F; Kato M; Shiro M; Ichimura A; Kinoshita I; Mikuriya M; Inohara T; Kawabe K; Sakurai H; Orvig C; Yano S
J Inorg Biochem; 2004 Jan; 98(1):105-12. PubMed ID: 14659639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
